# John M.S. Bartlett

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-m-s-bartlett/

## Facts

| Field | Value |
| --- | --- |
| Citations | 68,201 |
| Field | Breast Cancer Treatment Studies |
| h-index | 95 |
| i10-index | 304 |
| Last Known Institution | Edinburgh Cancer Research |
| OpenAlex ID | https://openalex.org/A5091359426 |
| ORCID iD | https://orcid.org/0000-0002-0347-3888 |
| Works | 732 |

## Researcher papers

- [Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials](https://scholariq.org/papers/long-term-outcomes-for-neoadjuvant-versus-adjuvant-chemotherapy-in-early-breast/)
- [Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group](https://scholariq.org/papers/assessment-of-ki67-in-breast-cancer-updated-recommendations-from-the/)
- [Multi-omic machine learning predictor of breast cancer therapy response](https://scholariq.org/papers/multi-omic-machine-learning-predictor-of-breast-cancer-therapy-response/)
- [Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations](https://scholariq.org/papers/guidelines-for-human-epidermal-growth-factor-receptor-2-testing-biologic-and/)
- [Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials](https://scholariq.org/papers/increasing-the-dose-intensity-of-chemotherapy-by-more-frequent-administration-or/)
- [Addressing overtreatment of screen detected DCIS; the LORIS trial](https://scholariq.org/papers/addressing-overtreatment-of-screen-detected-dcis-the-loris-trial/)
- [w4200350191](https://scholariq.org/papers/w4200350191/)
- [The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group](https://scholariq.org/papers/the-tale-of-tils-in-breast-cancer-a-report-from-the-international-immuno/)
- [Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials](https://scholariq.org/papers/anthracycline-containing-and-taxane-containing-chemotherapy-for-early-stage/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [Edinburgh Cancer Research](https://scholariq.org/institutions/edinburgh-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.